Clostridium Difficile Infection (CDI) Clinical Trial
Official title:
Evaluation of Fidaxomicin in the Treatment of Clostridium Difficile Infection (CDI)
This is a single center collection of discarded biological samples and electronic medical review (EMR) data on patients who are hospitalized with clostridium difficile infections and treated with Fidaxomicin
This single site study will be a clinical research data base of patients hospitalized and diagnosed with Clostridium difficile infection (CDI), treated with Fidaxomicin and willing to allow us to collect discard biological samples for testing and analysis in the investigators lab. An additional blood sample will be obtained if a clinically indicated bronchoscopy is performed as to measure the amount of medication in the BAL. We will also complete a medical record review will also occur. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04121169 -
Treatment of Mild-moderate Clostridium Difficile Infection (CDI)
|
Phase 2 | |
| Completed |
NCT02692651 -
A Comparison of Fidaxomicin and Vancomycin in Patients With CDI Receiving Antibiotics for Concurrent Infections
|
Phase 4 | |
| Completed |
NCT03244644 -
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)
|
Phase 3 | |
| Completed |
NCT02437591 -
Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI)
|
Phase 4 |